About this journal

Aims and scope

Expert Review of Proteomics  [ISSN 1478-9450]; [e-ISSN 1744-8387] is a MEDLINE-indexed, international journal publishing rigorously peer-reviewed review articles and original research focusing on clinical aspects of proteomics. The journal publishes both Gold Open Access and Subscription content.

Expert Review of Proteomics publishes reviews, commentary and original research from the fields of clinical and translational proteomics and related fields to advance scientific understanding of the many varied roles protein expression plays in human health and disease. Papers focus on studies of the following to understand their role in clinical health (including how these can advance therapeutics) and the value that this has for precision medicine and patients generally:

- Biological pathways and proteins on a human cellular and tissue level

- Functional and structural proteomics

- Quantitative and qualitative profiling

- Evaluations, recent advancements, discoveries, observation, applications, implications, interactions, diagnostics, prognostics, proteomic profiling techniques and technological developments in the following:

  • Biological mass spectrometry 
  • Protein arrays 
  • Interaction maps 
  • Data archives 
  • Biological assays 
  • Performance of new technologies and prospects for future drug discovery 

We encourage articles that discuss the combination of proteomics with lipidomics, glycomics, metabolomics, epigenomics and multi-omics. Please note that the journal does not publish case reports or case series.

Comprehensive coverage in each review is complemented by the unique Expert Collection format and includes the following sections:

Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results;

Article Highlights – an executive summary of the author’s most critical points.

Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees.

For any pre-submission enquiries, please contact the Commissioning Editor.

Journal metrics

Usage

  • 141K annual downloads/views

Citation metrics

  • 3.8 (2023) Impact Factor
  • Q1 Impact Factor Best Quartile
  • 4.4 (2023) 5 year IF
  • 7.6 (2023) CiteScore (Scopus)
  • Q2 CiteScore Best Quartile
  • 0.740 (2023) SNIP
  • 0.985 (2023) SJR

Speed/acceptance

  • 17 days avg. from submission to first decision
  • 8 days avg. from acceptance to online publication
  • 57% acceptance rate

Editorial board

Co-Editors

Christoph Borchers, Lady Davis Institute for Medical Research, Quebec, Canada

Rene Zahedi, Lady Davis Institute for Medical Research, Quebec, Canada

Editorial Board

Geert Baggerman, VITO (Flemish Institute for Technological Research), Belgium

Jonathan Blackburn, University of Cape Town, South Africa

Richard Burchmore, University of Glasgow, UK

William Cho, Queen Elizabeth Hospital, Hong Kong

Jasminka Godovac Zimmermann, University College London, United Kingdom

Canhua Huang, National Key Laboratory of Biotherapy, West China Hospital, Sichuan University, China

Thomas Joos, University of Tuebingen, Germany

Tadashi Kondo, National Cancer Center Research Institute, Japan

Lydie Lane, wiss Institute of Bioinformatics, Switzerland

Lance Liotta, George Mason University, VA, USA

Stefania Mondello, University of Messina, Messina, Italy

Kazuyuki Nakamura, Yamaguchi University School of Medicine, Japan

Edouard Nice, Monash University, Australia

Andrew Ottens, Virginia Commonwealth University, VA, USA

Emanuel Petricoin III, George Mason University, VA, USA

Wei-Jun Qian, Pacific Northwest National Laboratory, Richland, WA, USA

Om Singh, The Johns Hopkins School of Medicine, MD, USA

Gary Smejkal, Hubbard Center for Genome Studies, University of New Hampshire, Durham, NH, USA

Christopher Southan, IUPHAR Database, TW2Informatics, Sweden

Visith Thongboonkerd, Mahidol University, Thailand

Rui Vitorino, University of Aveiro, Portugal

Kui Wang, National Key Laboratory of Biotherapy, West China Hospital, Sichuan University, China

Tesshi Yamada, National Cancer Center Research Institute, Japan

Petra Zürbig, mosaiques diagnostics GmbH, Hannover, Germany

Abstracting and indexing

Expert Review of Proteomics

is included in the following abstracting and indexing services:

EMBASE/Excerpta Medica; Biological Abstracts; Biobase; BIOSIS Previews; Chemical Abstracts; EMBASE/Excerpta Medica; Index to Scientific Reviews®; Journal Citation Reports/Science Edition; MEDLINE/Index Medicus; Science Citation Index Expanded™ (SciSearch®); Scopus.

Open access

Expert Review of Proteomics is a hybrid open access journal that is part of our Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.

Why choose open access?

  1. Increase the discoverability and readership of your article
  2. Make an impact and reach new readers, not just those with easy access to a research library
  3. Freely share your work with anyone, anywhere
  4. Comply with funding mandates and meet the requirements of your institution, employer or funder
  5. Rigorous peer review for every open access article

Article Publishing Charges (APC)

If you choose to publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis.

Use our APC finder to calculate your article publishing charge

Advertising information

Would you like to advertise in Expert Review of Proteomics?

Reach an engaged target audience and position your brand alongside authoritative peer-reviewed research by advertising in Expert Review of Proteomics.

Explore advertising solutions

Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors, make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .

Ready to submit?

Start a new submission or continue a submission in progress

Go to submission site (link opens in a new window) Instructions for authors